Harvest Group Wealth Management’s GSK GSK Stock Holding History

Harvest Group Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-502	Closed	-$23K	–	299
2020 Q4	$23K	Buy	502 +8	+2%	+$367	0.01%	163
2020 Q3	$23K	Buy	494 +5	+1%	+$251	0.02%	157
2020 Q2	$24K	Buy	489 +7	+1%	+$359	0.02%	142
2020 Q1	$22K	Buy	482 +5	+1%	+$267	0.02%	133
2019 Q4	$28K	Buy	477 +5	+1%	+$278	0.02%	120
2019 Q3	$25K	Buy	472 +6	+1%	+$309	0.03%	136
2019 Q2	$23K	Buy	466 +6	+1%	+$301	0.03%	141
2019 Q1	$24K	Buy	+460	New	+$23K	0.02%	145

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Harvest Group Wealth Management's GSK Position: Q1 2021 in Review

Harvest Group Wealth Management sold out of GSK (GSK) in Q1 2021, closing a stake of 502 shares — an estimated $23K sold.

Harvest Group Wealth Management first reported a position in GSK in Q1 2019 and held it in 8 quarters. The position peaked at $28K in Q4 2019. 774 funds tracked by Wall St. Rank hold GSK as of Q1 2021.

Harvest Group Wealth Management reported no remaining GSK position as of Q1 2021 after selling out during the quarter.
Harvest Group Wealth Management sold 502 GSK shares in Q1 2021, an estimated $23K.
Harvest Group Wealth Management first reported a position in GSK in Q1 2019 and held it in 8 quarters.
Harvest Group Wealth Management's GSK position peaked at $28K in Q4 2019.
774 funds tracked by Wall St. Rank held GSK as of Q1 2021.

Based on Harvest Group Wealth Management's 13F filing for Q1 2021, filed 4 May 2021.